Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) FCF Margin (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported FCF Margin over the past 16 years, most recently at 8.92% for Q2 2025.

  • For Q2 2025, FCF Margin fell 693.0% year-over-year to 8.92%; the TTM value through May 2025 reached 10.57%, up 357.0%, while the annual FY2025 figure was 10.57%, 357.0% up from the prior year.
  • FCF Margin for Q2 2025 was 8.92% at Lifecore Biomedical, Inc. \De\, up from 12.57% in the prior quarter.
  • Over five years, FCF Margin peaked at 55.97% in Q2 2022 and troughed at 102.32% in Q1 2022.
  • A 5-year average of 17.53% and a median of 17.89% in 2022 define the central range for FCF Margin.
  • Biggest five-year swings in FCF Margin: tumbled -10337bps in 2021 and later skyrocketed 7053bps in 2023.
  • Year by year, FCF Margin stood at 9.94% in 2021, then tumbled by -385bps to 28.36% in 2022, then soared by 79bps to 5.94% in 2023, then plummeted by -335bps to 25.85% in 2024, then surged by 134bps to 8.92% in 2025.
  • Business Quant data shows FCF Margin for LFCR at 8.92% in Q2 2025, 12.57% in Q1 2025, and 25.85% in Q4 2024.